Tech Company Financing Transactions
Kytopen Funding Round
On 4/7/2026, Kytopen raised Series B funding from Telegraph Hill Partners and private investors.
Transaction Overview
Company Name
Announced On
4/7/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
Telegraph Hill Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate its global commercial expansion and drive further adoption of its Flowfect technology platform across the U.S. and Europe.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
501 Massachusetts Ave. The Engine Ecosystem
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Kytopen is an MIT startup developing their proprietary Flowfect technology for non-viral delivery of molecules into hard-to-transfect immune cells. The scalable Flowfect technology combines microfluidics and automation to make this process easier, faster, and cheaper than ever before.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paulo Garcia
Chief Operating Officer
Michael Elliott
Co-Founder
Cullen Buie
VP - Bus. Development
Gregory Crescenzi
VP - Engineering
Norman Wen
VP - R & D
Bethany Grant
Browse more venture capital transactions:
Prev: 4/7/2026: TerraCycle venture capital transaction
Next: 4/7/2026: Mappedin venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs